Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Annie Lewis-O'Connor, PhD, NP-BC, MPH, FAAN
Contributor
Dr. Annie Lewis-O’Connor is a dually board certified (pediatrics and women’s health) nurse practitioner. She is the founder and director of the C.A.R.E. Clinic (Coordinated Approach to Resiliency & Empowerment) at Brigham and Women’s Hospital, Boston, MA; an associate scientist in the division of women’s health/department of medicine at BWH; and an instructor at Harvard Medical School.
Dr. Lewis-O’Connor addresses violence from four pillars: research, policy, education, and clinical practice. She was a clinical scholar with the Robert Wood Johnson Foundation (2018–2021). Since 2012, she has served as co-chair of the Mass General Brigham Trauma-Informed Care Initiative.
She received her master’s in nursing from Simmons College in Boston, a master’s in public health from Boston University, and her PhD from Boston College.
Posts by Annie Lewis-O'Connor, PhD, NP-BC, MPH, FAAN
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine